Identification of a P-Glycoprotein-Deficient Subpopulation in the CF-1 Mouse Strain Using a Restriction Fragment Length Polymorphism
- 30 September 1997
- journal article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 146 (1), 88-94
- https://doi.org/10.1006/taap.1997.8225
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- P-Glycoprotein Deficiency in a Subpopulation of CF-1 Mice Enhances Avermectin-Induced NeurotoxicityToxicology and Applied Pharmacology, 1997
- What have we learnt thus far from mice with disrupted P-glycoprotein genes?European Journal of Cancer, 1996
- Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammalsPharmacology & Therapeutics, 1993
- The Chemistry and Pharmacology of AvermectinsAnnual Review of Pharmacology and Toxicology, 1992
- Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodiesBritish Journal of Cancer, 1992
- Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells.Molecular and Cellular Biology, 1990
- Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.Proceedings of the National Academy of Sciences of the United States of America, 1990
- P‐glycoproteins encoded by mdr 1b in murine gravid uterus and multidrug resistant tumor cell lines are differentially glycosylatedFEBS Letters, 1989
- The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues.Molecular and Cellular Biology, 1989
- The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus.Proceedings of the National Academy of Sciences of the United States of America, 1988